MedTrace Logo

Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis

NCT05202860 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-01-22

No results posted yet for this study

Summary

A double-blind, randomized, placebo controlled intervention trial on patients with actinic keratosis.

Conditions

Interventions

BIOLOGICAL

HPV Vaccine

(Gardasil 9 human papilloma vaccine)

BIOLOGICAL

PLACEBO vaccine

Isotonic saltwater sham vaccine

Sponsors & Collaborators

  • Merete Haedersdal

    lead OTHER

Principal Investigators

  • Merete Haedersdal, MD, PhD, DMSc · Bispebjerg Hospital

  • Emily Wenande, MD, PhD · Bispebjerg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-09
Primary Completion
2024-06-19
Completion
2034-06-19

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05202860 on ClinicalTrials.gov